Login

Glaxosmithkline Pharmaceuticals Ltd.

₹2936.5

Overview Charts Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Corp. Action Documents
Consolidated
Standalone

Glaxosmithkline Pharmaceuticals Ltd.

Add Alert
Add Watchlist

₹2936.5

₹2936.5

-226.1 (-7.15%) - 2 Aug 2025 04:25 PM

About Company

Glaxosmithkline Pharmaceuticals Limited is engaged in research, manufacture and make available a broad range of medicines and vaccines that benefit people. The company’s Pharmaceuticals business has a broad portfolio of innovative and established medicines with commercial leadership in anti-infectives and dermatology. Its R&D approach focuses on science related to the immune system, use of genetics and advanced technologies. Meanwhile, Its Vaccines business has a broad portfolio and innovative pipeline of vaccines to protect people of all ages. The company is the leaders in India in the private segment.

Market Cap. ₹ 49,746 Cr.
52 Week - High/Low ₹ 3,516/1,921
P/E Ratio 52.81
P/B Ratio 25.52
Enterprise Value ₹ 48,455 Cr.
ROE % 48.92
RSI Value 27.35
EMA 50 3150.73
EMA 200 2814.35
Market Cap. ₹ 49,746 Cr.
52 Week - High/Low ₹ 3,516/1,921
P/E Ratio 52.35
P/B Ratio 25.49
Enterprise Value ₹ 48,453 Cr.
ROE % 49.43
RSI Value 27.35
EMA 50 3150.73
EMA 200 2814.35
Add Parameters

Growth

Chart Icon
View Full Chart

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Terms | Privacy | Contact Us
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.